Antimicrobial Agents and ChemotherapyGeneticsPeer-reviewed journal article
N-acetyltransferase 2 genotypes amongst ulu Speaking South Africans and isoniazid / N-acetyl-isoniazid pharmacokinetics during ant-tuberculosis treatment
Thuli MthiyaneiD, James MillardiD, John AdamsoniD, Yusentha BalakrishnaiD, Cathy ConnollyiD, Andrew OweniD, Roxana Rustomjee, Keertan U.J. DhedaiD, Helen McIlleroniD, Alexander S. PymiD
Abstract
BackgroundDistribution of N-acetyltransferase2 (NAT2) polymorphisms varies considerably among different ethnic groups. Information on NAT2 single-nucleotide polymorphisms in South African population is limited. We investigated NAT2 polymorphisms and their effect on isoniazid pharmacokinetics in Zulu black HIV-infected South Africans in Durban, South Africa. Methods: HIV-infected participants with culture-confirmed pulmonary tuberculosis (TB) were enrolled from two unrelated studies. Culture-confirmed participants were genotyped for NAT2 polymorphisms 282C>T, 341T>C, 481C>T, 857G>A, 590G>A and 803A>G using Life Technologies pre-validated Taqman assays (Life Technologies, Paisley, UK). Participants underwent sampling for determination of plasma isoniazid and N-acetylisoniazid concentrations. ResultsAmongst the 120 patients, 63/120 (52.5%) were slow metabolisers (NAT2*5/*5), 43/120 (35.8%) had intermediate (NAT2*5/12), and 12/120 (11.7%) had rapid genotype (NAT2*4/*11, NAT2*11/12 and NAT2*12/12). NAT2 alleles in this study were *4, *5C, *5D, *5E, *5J, *5K, *5KA, *5T, *11A, *12A/12C and *12M. NAT2*5 was the most frequent allele (70.4%) followed by NAT2*12 (27.9%). 34/40 had both PK results and NAT2 genotyping results. The median area under the concentration-time-curve to infinity (AUC0-{infty}) interquartile range (IQR) was 7.81 (5.87 - 16.83) g/ml/hr and maximum concentration (Cmax) 3.14 g/ml (2.42 - 4.36) g/mL. Individual polymorphisms were not equally distributed, with some represented in small numbers. Genotype did not correlate with phenotype, rapid genotype showing higher AUC0-{infty} than slow but not significant, p=0.43. ConclusionThere was high prevalence of slow followed by intermediate then rapid acetylator genotypes. The poor concordance between genotype and phenotype suggests that other factors or genetic loci influence INH metabolism, and warrants further investigation in this population.
- Citations
- 31
- FWCI
- 4.19
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Allelic and Genotypic Frequencies of NAT2, CYP2E1 and AADAC genes in a cohort of Peruvian Tuberculosis Patients
Kelly S. Levano, Luis Jaramillo‐Valverde, … Heinner Guio·Molecular Genetics & Genomic MedicinePeer-reviewed·Sep 12, 2021
- In-silico functional prediction of novel tuberculosis pharmacogenetic variants and NAT2 phenotype prediction in African populations
Carola Oelofse, Marlo Möller, Caitlin Uren·medRxiv·Aug 19, 2026
- Acetylation of isoniazid - a novel mechanism of isoniazid resistance in Mycobacterium tuberculosis
A. K B, A. Madhavan, … A. K. R·bioRxiv·Feb 10, 2020
- Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis
Lourdes Encinas, Si-Yang Li, … Eric L. Nuermberger·bioRxiv·Mar 8, 2024
- Resistance Rate Distribution of MDR-TB Among Pulmonary Tuberculosis Patients Attending Nnamdi Azikiwe University Teaching Hospital Nnewi and ST Patrick’S Hospital Mile 4 Abakiliki in Southeast Nigeria
C. E. Okoro, C. N. Akujobi, … A. C. Okpe·bioRxiv·Mar 9, 2019
- Mutations in Rv2983 as a novel determinant of resistance to nitroimidazole drugs in Mycobacterium tuberculosis
Dalin Rifat, Si-Yang Li, … Eric Nuermberger·bioRxiv·Oct 31, 2018